Skip to main content

Published locations for Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery

User login

  • Reset your password
  • /content/ipilimumab-or-high-dose-interferon-alfa-2b-treating-patients-high-risk-stage-iii-or-stage-iv
  • /oncologypractice/article/56302/melanoma/ipilimumab-or-high-dose-interferon-alfa-2b-treating-patients
  • /hematology-oncology/article/56302/melanoma/ipilimumab-or-high-dose-interferon-alfa-2b-treating